JP2015535839A5 - - Google Patents

Download PDF

Info

Publication number
JP2015535839A5
JP2015535839A5 JP2015533635A JP2015533635A JP2015535839A5 JP 2015535839 A5 JP2015535839 A5 JP 2015535839A5 JP 2015533635 A JP2015533635 A JP 2015533635A JP 2015533635 A JP2015533635 A JP 2015533635A JP 2015535839 A5 JP2015535839 A5 JP 2015535839A5
Authority
JP
Japan
Prior art keywords
alkyl
carboxylic acid
compound
amino
heteroarylalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015533635A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015535839A (ja
JP6298998B2 (ja
Filing date
Publication date
Priority claimed from EP12306196.2A external-priority patent/EP2712866A1/en
Application filed filed Critical
Publication of JP2015535839A publication Critical patent/JP2015535839A/ja
Publication of JP2015535839A5 publication Critical patent/JP2015535839A5/ja
Application granted granted Critical
Publication of JP6298998B2 publication Critical patent/JP6298998B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015533635A 2012-10-01 2013-10-01 ウイルス感染を治療するための1,2,4−トリアジン誘導体 Expired - Fee Related JP6298998B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12306196.2A EP2712866A1 (en) 2012-10-01 2012-10-01 1,2,4-triazine derivatives for the treatment of viral infections
EP12306196.2 2012-10-01
PCT/EP2013/070488 WO2014053516A1 (en) 2012-10-01 2013-10-01 1,2,4-triazine derivatives for the treatment of viral infections.

Publications (3)

Publication Number Publication Date
JP2015535839A JP2015535839A (ja) 2015-12-17
JP2015535839A5 true JP2015535839A5 (enExample) 2016-11-10
JP6298998B2 JP6298998B2 (ja) 2018-03-28

Family

ID=46982496

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015533635A Expired - Fee Related JP6298998B2 (ja) 2012-10-01 2013-10-01 ウイルス感染を治療するための1,2,4−トリアジン誘導体

Country Status (21)

Country Link
US (1) US9416114B2 (enExample)
EP (2) EP2712866A1 (enExample)
JP (1) JP6298998B2 (enExample)
KR (1) KR102138393B1 (enExample)
CN (1) CN104812747B (enExample)
AU (1) AU2013326579B2 (enExample)
BR (1) BR112015007310B1 (enExample)
CA (1) CA2886630C (enExample)
CL (1) CL2015000787A1 (enExample)
EA (1) EA026236B1 (enExample)
ES (1) ES2616496T3 (enExample)
IL (1) IL237871A (enExample)
IN (1) IN2015DN03327A (enExample)
MX (1) MX348229B (enExample)
MY (1) MY182558A (enExample)
NZ (1) NZ706354A (enExample)
PH (1) PH12015500724A1 (enExample)
SG (1) SG11201502522WA (enExample)
UA (1) UA114644C2 (enExample)
WO (1) WO2014053516A1 (enExample)
ZA (1) ZA201502240B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101946499B1 (ko) 2011-04-08 2019-02-11 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 바이러스 감염 치료를 위한 피리미딘 유도체
UA116083C2 (uk) 2011-11-09 2018-02-12 ЯНССЕН САЙЄНСІЗ АЙРЛЕНД ЮСі Похідні пурину для лікування вірусних інфекцій
PT2872515T (pt) 2012-07-13 2016-07-27 Janssen Sciences Ireland Uc Purinas macrocíclicas para o tratamento de infeções virais
EA035327B1 (ru) 2012-10-10 2020-05-28 Янссен Сайенсиз Айрлэнд Юси Производные пирроло[3,2-d]пиримидина для лечения вирусных инфекций и других заболеваний
ES2655843T3 (es) 2012-11-16 2018-02-21 Janssen Sciences Ireland Uc Derivados 2-aminoquinazolínicos sustituidos heterocíclicos para el tratamiento de infecciones víricas
MY191389A (en) 2013-02-21 2022-06-22 Janssen Sciences Ireland Uc 2-aminopyrimidine derivatives for the treatment of viral infections
CN105338983B (zh) 2013-03-29 2019-10-25 爱尔兰詹森科学公司 用于治疗病毒感染的大环脱氮-嘌呤酮
JP6377139B2 (ja) 2013-05-24 2018-08-22 ヤンセン・サイエンシズ・アイルランド・ユーシー ウイルス感染症およびさらなる疾患の処置のためのピリドン誘導体
JP6763769B2 (ja) 2013-06-27 2020-09-30 ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー ウイルス感染症および他の疾病の処置のためのピロロ[3,2−d]ピリミジン誘導体
MX368625B (es) 2013-07-30 2019-10-08 Janssen Sciences Ireland Uc Derivados de tieno[3,2-d]pirimidinas para el tratamiento de infecciones virales.
SG11201811448RA (en) 2016-07-01 2019-01-30 Janssen Sciences Ireland Unlimited Co Dihydropyranopyrimidines for the treatment of viral infections
KR102450287B1 (ko) * 2016-09-29 2022-09-30 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 바이러스 감염 및 추가적인 질환의 치료를 위한 피리미딘 프로드러그
TW202415645A (zh) 2018-03-01 2024-04-16 愛爾蘭商健生科學愛爾蘭無限公司 2,4-二胺基喹唑啉衍生物及其醫學用途
BR112021015577A8 (pt) 2019-02-08 2021-10-05 Research & Business Found Sungkyunkwan Univ Complexo-colesterol agonista do receptor toll-like 7/8, composição de nanopartícula, composição adjuvante, composição de vacina, composição para regular uma função imunológica, composição farmacêutica e uso do complexo
EP4115901A4 (en) 2020-03-02 2024-04-10 Progeneer Inc. Live-pathogen-mimetic nanoparticles based on pathogen cell wall skeleton, and production method thereof
EP4194008A4 (en) 2020-08-04 2025-01-08 Progeneer Inc. Kinetically acting adjuvant ensemble
WO2022031021A1 (ko) 2020-08-04 2022-02-10 성균관대학교산학협력단 동력학적 제어가 가능한 아주번트를 포함하는 mrna 백신
EP4194010A4 (en) 2020-08-04 2025-03-26 Progeneer Inc. Conjugate of a functional drug and a toll-like receptor 7 or 8 agonist with a temporarily inactivated drug site, and use thereof
WO2024151953A1 (en) * 2023-01-15 2024-07-18 Viradem Inc. Compounds and methods for treating diseases caused by sars-cov-2 and other coronaviruses

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2485531A1 (fr) * 1980-06-25 1981-12-31 Fabre Sa Pierre Nouveaux n-oxydes de diaryl-5,6 as triazines 1-2-4, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
TW552261B (en) 1996-07-03 2003-09-11 Japan Energy Corp Novel purine derivative
CA2311742C (en) 1997-11-28 2009-06-16 Sumitomo Pharmaceuticals Co., Ltd. 6-amino-9-benzyl-8-hydroxypurine derivatives
RU2401833C2 (ru) * 2004-08-10 2010-10-20 Янссен Фармацевтика Н.В. Производные 1, 2, 4-триазин-6-она, ингибирующие вич
MX2007013780A (es) 2005-05-04 2008-02-05 Pfizer Ltd Derivados 2 amido-6-amino-8-oxo purina como moduladores del receptor como tipo peaje (toll) para el tratamiento del cancer y las infecciones virales tal como la hepatitis c.
ES2612890T3 (es) * 2005-09-01 2017-05-19 F. Hoffmann-La Roche Ag Diaminopirimidinas como moduladores de P2X3 y P2X2/3
RU2352565C1 (ru) * 2007-10-08 2009-04-20 Государственное образовательное учреждение высшего профессионального образования "Пермский государственный университет" 3-амино-6-ароилметил-5-гидрокси-1,2,4-триазины и способ их получения
PE20091236A1 (es) * 2007-11-22 2009-09-16 Astrazeneca Ab Derivados de pirimidina como immunomoduladores de tlr7
WO2012067269A1 (en) * 2010-11-19 2012-05-24 Dainippon Sumitomo Pharma Co., Ltd. Aminoalkoxyphenyl compounds and their use in the treatment of disease

Similar Documents

Publication Publication Date Title
HRP20200538T1 (hr) Derivati pirimidina za liječenje virusnih infekcija
SI2906563T1 (en) Derivatives of pyrrolo (3,2-d) pyrimidine for the treatment of viral infections and other diseases
PH12019502370A1 (en) Salt of an aminopyridine derivative compound, a crystalline form thereof, and a process for preparing the same
JP2015537020A5 (enExample)
NZ627036A (en) Piperidino-pyrimidine derivatives for the treatment of viral infections
HRP20180447T1 (hr) Derivati kinazolina za liječenje virusnih infekcija i drugih bolesti
JP2016530259A5 (enExample)
JP2016519165A5 (enExample)
EP3954679A3 (en) Amide compounds for the treatment of hiv infections
JP2016540742A5 (enExample)
JP2017523225A5 (enExample)
RU2014141579A (ru) Гетероциклические соединения в качестве ингибиторов бета-лактамаз
JP2014514360A5 (enExample)
JP2016522172A5 (enExample)
JP2017533968A5 (enExample)
JP2014506907A5 (enExample)
JP2015509535A5 (enExample)
JP2016518305A5 (enExample)
JP2015520140A5 (enExample)
JP2016535732A5 (enExample)
JP2015535847A5 (enExample)
JP2018529690A5 (enExample)
JP2018502101A5 (enExample)
JP2017517565A5 (enExample)
JP2020527175A5 (enExample)